SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

ABT Licenses Alzheimer's Diagnostic

Abbott signs licensing agreement with ALZpath for its proprietary phosphorylated tau 217 antibody

ABT

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.